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Summary The Japanese acute coronary syndrome study (JACSS) is a retrospective
and multicenter observational study conducted in 35 medical institutions across
Japan. The JACSS database included 5325 consecutive patients hospitalized at the
participating institutions within 48 h after the onset of symptoms of acute myocar-
dial infarction (AMI) between January 2001 and December 2003. The JACSS data
vividly displayed the modern state of AMI in the interventional era. Percutaneous
coronary intervention (PCI) including balloon angioplasty and stent implantation was
performed in 80% of the patients and approximately 90% of the treated patients had
successful coronary recanalization during the acute phase of MI. The results showed
very low rates of all-cause mortality and cardiovascular deaths during hospitaliza-
tion. Various types of novel information have been produced from JACSS data by
several leading clinical researchers in Japan and this may also be helpful in making
plans for a prospective study.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
reserved.
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Table 1A Retrospective study on prognosis of
patients with AMI-JACSS data-subjects: consecutive
patients hospitalized within 48 h after the onset of
symptoms of AMI from January 2001 to December 2003
(n = 5325).
Age 68± 12 (22—103) years
Sex:men 71%
Hypertension
(SBP > 140mmHg and/or
DBP > 90mmHg)
57%
Diabetes mellitus
(FBS > 126mg/dL or 75 g
OGTT2 h > 200mg/dL)
32%
Hyperlipidemia (total
cholesterol > 220mg/dL
and/or triglyc-
eride > 150mg/dL)
34%
Smoking (active smoking
or smoking within 2
years)
47%
Obesity (body mass
index > 25 kg/m2)
30%
Old myocardial infarction 13%
Time from onset to
hospital admission
6.5± 8.6 h
Q wave myocardial
infarction
71%
Preinfarction angina
Sudden onset 69%
Effort angina 14%
Rest angina 17%
ST-T change on admission
ST elevation 88%
ST depression 12%
Killip classiﬁcation
I 78%
II 7%
III 4%
IV 8%
Unknown 3%
AMI, acute myocardial infarction; DBP, diastolic blood pres-References ..........................................
Introduction
The Japanese acute coronary syndrome study
(JACSS) is a retrospective and multicenter obser-
vational study conducted in 35 medical institutions
across Japan. The JACSS database included 5325
consecutive patients hospitalized at the partici-
pating institutions within 48 h after the onset of
symptoms of acute myocardial infarction (AMI)
between January 2001 and December 2003.
Tables 1A and 1B show the clinical and angio-
graphic characteristics of the patients and the
state of AMI in the intervention era. Percutaneous
coronary intervention (PCI) including balloon angio-
plasty and stent implantation was performed in
80% of the patients and approximately 90% of the
treated patients had successful coronary recanal-
ization (thrombolysis in myocardial infarction [TIMI]
[1] III) during the acute phase of MI. The results
showed very low rates of all-cause mortality (8%)
and cardiovascular deaths (7%) during hospitaliza-
tion. Several leading clinical researchers in Japan
have used data of the JACSS in their analysis
[2—14].
Risk factors for AMI in Japanese men
and women
Current knowledge about the prevention of coro-
nary heart disease and cardiovascular disease is
mainly derived from studies in European popula-
tions [15]. However, the extent to which these
ﬁndings apply worldwide is unknown. Some stud-
ies reported that risk factors for coronary artery
disease vary in different geographic regions, espe-
cially Asian countries. For example, dyslipidemia is
not a risk factor for coronary artery disease in India
[16] and hypertension is more important in China
[17]. In addition, the incidence of ischemic heart
disease in Japan has been reported to be the lowest
among the developed countries [18,19]. The differ-
ences between Japan and western countries may
stem, in part, from genetic factors, but it is more
likely that eating habits are the cause; for exam-
ple, the average plant-based low-fat diet. Kawano
e
J
p
psure; FBS, fasting blood sugar; JACSS, Japanese acute
coronary syndrome study; OGTT, oral glucose tolerance test;
SBP, systolic blood pressure.t al. [9] clariﬁed the risk factors for AMI in the
apanese population. Risk factors were assessed in
atients with a ﬁrst AMI and age- and sex-matched
opulation-based controls. Hypertension, diabetes,
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Table 1B Retrospective study on prognosis of
patients with AMI-JACSS data-subjects: consecutive
patients hospitalized within 48 h after the onset of
symptoms of AMI from January 2001 to December 2003
(n = 5325).
Acute phase
Coronary vessel involvement (n = 4827)
0—–vessel disease 1%
1—–vessel disease 54%
2—–vessel disease 29%
3—–vessel disease 16%
Target lesion stenosis (n = 4707)
AHA≤ 75% 3%
AHA≤ 90% 10%
AHA≤ 99% 25%
AHA≤ 100% 62%
Treatment
Conservative 15%
Thrombolysis 4%
Percutaneous old
balloon angioplasty
13%
(thrombolysis + balloon) 3%
Stent implantation 67%
(thrombolysis + stent) 8%
Coronary artery bypass
graft
1%
Peak creatine kinase
(n = 4916)
2896± 2938 IU/L
Final TIMI ﬂow
0 5%
1 1%
2 6%
3 88%
Left ventricular ejection
fraction (n = 2022)
51± 12%
Chronic phase
Left ventricular ejection
fraction (n = 2602)
55± 13%
Target lesion stenosis (n = 3404)
AHA≤ 90% (50%) 90% (79%)
Prognosis (n = 5302)
Prognosis during hospitalization
All cause mortality 8%
Cardiovascular death 7%
Long-term prognosis (mean follow-up period after
the onset of AMI: 412± 219 days)
Cardiovascular death 9%
Reinfarction 2%
Unstable angina 2%
Ischemic heart failure 3%
Stroke 1%
AHA, American Heart Association; AMI, acute myocardial
infarction; TIMI, Thrombolysis in Myocardial Infarction.
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urrent smoking, family history, and hypercholes-
erolemia were all independent risk factors for
MI (in both men and women) (Fig. 1A). However,
besity was not. Hypertension, current smoking,
nd diabetes were all independent risk factors for
MI in men. In contrast, only current smoking,
iabetes, and hypertension were independent risk
actors for AMI in women. Hypercholesterolemia
as an independent risk factor for AMI in men,
ut not in women (Fig. 1B). In conclusion, hyper-
ension, diabetes, current smoking, family history,
nd hypercholesterolemia are associated with AMI
n Japanese patients. In addition, there are sex
ifferences in the order of importance related to
isk factors for AMI. Hypertension, current smok-
ng, diabetes, and family history are the most
mportant risk factors in men, whereas current
moking, diabetes, hypertension, and family his-
ory are the most important risk factors in women.
ypercholesterolemia is an independent risk fac-
or for AMI in men, but not in women. This is
he ﬁrst clinical study that deﬁnes the relative
mportance of risk factors for AMI in Japanese
atients.
eneﬁcial effects of preinfarction
ngina on in-hospital outcome
n experimental animals, brief episodes of ischemia
efore sustained coronary occlusion signiﬁcantly
ecrease infarct size [20—22]. This phenomenon,
nown as ischemic preconditioning, also occurs
n humans. Several clinical studies have demon-
trated that angina attacks shortly before the
nset of AMI limit infarct size and improve
oth short- and long-term outcomes [23—26].
owever, the clinical signiﬁcance of preinfarc-
ion angina in patients with AMI who undergo
CI is not known. Kosuge et al. [2] assessed
he relationship between preinfarction angina,
nfarct size, and in-hospital outcome after PCI
or AMI. They reported that preinfarction angina
ccurring ≤24 h before the onset of AMI was
ssociated with lower peak creatine kinase lev-
ls (Fig. 2A) and lower in-hospital mortality in
atients who underwent PCI for anterior infarction
Fig. 2B). This beneﬁcial effect of preinfarc-
ion angina on in-hospital outcome was less
bvious in patients with non-anterior infarction.
previous report described a favorable effect
f preinfarction angina on in-hospital outcome
n both anterior and non-anterior infarctions
lthough only 19% of patients underwent PCI
27].
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Figure 1 (A) Overall odds ratios for individual risk factors. (B) Sex differences in the odds ratios for individual risk
factors. AMI, acute myocardial infarction.
Figure 2 (A) Overall, peak creatine kinase was signiﬁcantly lower in patients with (white bars) than without (black
bars) preinfarction angina. In patients with anterior infarction, peak creatine kinase was signiﬁcantly lower in those
with (white bars) than without (black bars) preinfarction angina. In patients with non-anterior infarction, peak creatine
kinase level did not differ signiﬁcantly according to the presence (white bars) or absence (black bars) of preinfarction
angina. **P < 0.01 versus patients without preinfarction angina. (B) Overall, in-hospital mortality was signiﬁcantly lower
in patients with (white bars) than without (black bars) preinfarction angina. In patients with anterior infarction, in-
hite
y did
0.0
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ahospital mortality was signiﬁcantly lower in those with (w
patients with non-anterior infarction, in-hospital mortalit
bars) or absence (black bars) of preinfarction angina. *P <
Leukocyte count and predictor of
mortality
Inﬂammation is a signiﬁcant risk factor for the
development of coronary artery disease [28—30].
Recently, there has been a renewed interest in
leukocyte count as a prognostic indicator of acute
coronary syndrome [31]. The leukocyte count is a
simple and universally available marker of inﬂam-
mation and acute-phase reactants. Leukocytosis
was also considered a high risk factor for adverse
t
p
c
obars) than without (black bars) preinfarction angina. In
not differ signiﬁcantly according to the presence (white
5 versus patients without preinfarction angina.
vents following AMI in the era before coronary
eperfusion therapy [32—34]. Kojima et al. [3] eval-
ated whether leukocyte count in the acute phase
f MI predicts adverse in-hospital clinical outcomes
nd long-term prognosis in the coronary inter-
entional era. Leukocyte count was signiﬁcantly
ssociated with smoking, sudden onset AMI, and
he no-reﬂow phenomenon during PCI, as were age,
eak creatine kinase level, and Killip class. Leuko-
ytosis was signiﬁcantly associated with higher risk
f in-hospital mortality (Fig. 3). Patients in the
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Figure 3 Event-free survival of patients after AMI by
quartile of the leukocyte count. Quartile 1: leukocyte
count≤ 7800/mm3; Quartile 2: 7800/mm3 < leukocyte
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Figure 4 The in-hospital mortality rate increased as
plasma glucose increased (2% in patients with plasma
glucose≤ 90mg/dL, 3% in patients with plasma glu-
cose 90—126mg/dL, 5% in patients with plasma glucose
126—162mg/dL, 10% in patients with plasma glucose
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iount≤ 9750/mm3; Quartile 3: 9750/mm3 < leukocyte
ount < 12,100/mm3; Quartile 4: 12,100/mm3 < leukocyte
ount.
ighest quartile of leukocyte count were about
hree times more likely to have a poor prognosis
fter AMI compared to those in the lowest quar-
ile, after adjusting for independent factors which
ere closely associated with leukocyte count. They
oncluded that the leukocyte count is of great
igniﬁcance for stratifying patient risk and recom-
ended its use as a marker for predicting future
dverse events following treatment for AMI.
yperglycemia and adverse outcomes
n increase in plasma glucose concentration is
ften observed during the early hours after the
nset of AMI not only in diabetic patients but
lso in patients free of diabetes mellitus [35]. It
as been reported that both acute hyperglycemia
nd diabetes mellitus are independently associ-
ted with adverse outcomes after AMI in the
re-reperfusion era and in the thrombolytic era
36—41]. Ishihara et al. [7] assessed the associa-
ion between acute hyperglycemia and in-hospital
utcome after AMI in the contemporary PCI era. In
ddition, because acute hyperglycemia was often
onfused with chronic hyperglycemia, the asso-
iation between diabetes mellitus and outcome
fter AMI in the PCI era was also investigated.
he in-hospital mortality rate was signiﬁcantly
igher in patients with acute hyperglycemia than
n patients without. However, there was no sig-
iﬁcant difference in mortality between diabetic
nd non-diabetic patients. Acute hyperglycemia
as associated with a higher in-hospital mortality
t
r
A
t62—198mg/dL, 12% in patients with plasma glucose
98—234mg/dL, and 18% in patients with plasma glu-
ose > 234mg/dL; P < 0.001).
ate both in non-diabetic patients and in diabetic
atients. The in-hospital mortality increased as
lasma glucose increased (Fig. 4). Acute hyper-
lycemia was associated with a higher incidence
f no-reﬂow during PCI but diabetes was not.
hey concluded that acute hyperglycemia, but not
iabetes, was a predictor of in-hospital mortal-
ty after AMI in the PCI era. No-reﬂow occurred
ore frequently during PCI in patients with acute
yperglycemia, suggesting that microvascular dys-
unction might contribute to the adverse outcome
f such patients.
ther prognostic indicators of AMI
ther prognostic indicators of AMI in addition to
eukocyte count and hyperglycemia were exam-
ned. Post-AMI hyperuricemia was associated with
he development of heart failure [5]. Serum uric
cid level on admission was a suitable marker
or predicting AMI-related future adverse events
Fig. 5A), and the combination of Killip class and
ost-AMI serum uric acid level was a good predic-
or of mortality of patients with AMI (Fig. 5B) [5].
eukocyte count and plasma glucose level were
ndependently associated with in-hospital mortal-
ty suggesting that a simple combination of these
wo parameters might provide further information
egarding prediction of outcome in patients with
MI (Fig. 6) [10]. In another study, risk stratiﬁca-
ion based on the combined use of leukocyte count,
6 H. Ogawa, S. Kojima
Figure 5 (A) Survival without all-cause mortality in patients after acute myocardial infarction based on serum uric
acid concentrations of < 4.6mg/dL in quartile 1 (thin solid line), 4.6 to 5.6mg/dL in quartile 2 (short-dash line),
5.6—6.7mg/dL in quartile 3 (long-dash line), and > 6.7mg/dL in quartile 4 (thick solid line). (B) Survival without all-
cause mortality in patients after acute myocardial infarction based on combinations of the best uric acid cut-off
concentration of 7.5mg/dl for predicting survival and Killip’s class: Killip’s classes I and II plus a uric acid concentra-
tion≤ 7.5mg/dl (thin solid line), Killip’s classes I and II plus a uric acid concentration > 7.5mg/dl (short-dash line),
Killip’s classes III and IV plus a uric acid concentration≤ 7.5mg/dl (long-dash line), and Killip’s classes III and IV plus
a uric acid concentration > 7.5mg/dl (thick solid line). AMI, acute myocardial infarction.
Figure 6 In-hospital mortality across tertiles
of leukocyte count (low< 8300/mm3, medium
Figure 7 In-hospital mortality according to the number
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i8300—11,000/mm3, high > 11,000/mm3) and plasma
glucose level (low< 133mg/dl, medium 133—182mg/dl,
high > 182mg/dl).
plasma glucose, and glomerular ﬁltration rate on
admission provided important prognostic informa-
tion and facilitated early risk stratiﬁcation (Fig. 7)
[14].
Patients with AMI on a weekday or on
the weekend
Studies from North America report outcome dif-
ferences between patients admitted to acute care
hospitals on a weekday vs the weekend; that is,
the mortality rate of patients admitted on week-
ends tended to be higher [42,43]. The difference
b
o
z
Tf variables of high leukocyte count (>11,200/mm3), high
lasma glucose (>72.8mg/dL), and low glomerular ﬁltra-
ion rate (<60mL/min/1.73m2).
as interpreted to be related to low stafﬁng lev-
ls and availability of emergency procedures on the
eekends compared with weekdays [44,45]. How-
ver, it is not clear whether this is also applicable
o Japanese patients and hospitals. Matsui et al.
12] assessed the clinical outcomes for weekday
nd weekend admission to hospitals for patients
ith AMI in Japanese acute care hospitals. This
tudy included AMI patients with weekday onset
Monday through Friday) and those with weekend
nset (Saturday and Sunday). There were no signif-
cant differences between the 2 groups in patient
ackground and clinical features. The proportions
f patients who underwent emergency catheteri-
ation and reperfusion therapy were also similar.
here were no differences between the 2 groups
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Figure 8 (A) Comparison of cumulative total death rate after propensity score matching in the nitrate group and
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Tontrol group. (B) Comparison of cumulative rate of ca
nstable angina, heart failure requiring rehospitalization,
roup and control group. AMI, acute myocardial infarctio
n the in-hospital, 30-day, and 1-year mortality
ates. Even after various adjustments, there was
o difference in the risk of death associated with
eekend versus weekday onset of AMI. In con-
lusion, the results of that study showed similar
utcomes for patients who developed acute MI on
weekday or on the weekend. The results express
he similar quality of care in Japanese hospitals,
egardless of the day of the week.
s it true that nitrate treatment
ncreases future cardiac events?
n the coronary pre-interventional era, two
apanese studies examined the effects of nitrate
reatment in MI patients. However, the overall ran-
omization rate was rather low and data were
ot adjusted for patient background. There is no
linical evidence for clinical beneﬁts from nitrate
reatment in patients undergoing PCI in the acute
hase of MI. Another study was designed to deter-
ine the effects of long-term nitrate therapy on
dverse events in patients with AMI in the coro-
ary interventional era [11]. The results showed
hat all-cause mortality, cardiac, and cardiovas-
ular events were lower in patients treated with
itrates than untreated controls. However, these
l
t
s
i
rvascular events (cardiac death, non-fatal reinfarction,
ke) after propensity score matching between the nitrate
rude comparisons included several confounding
actors on nitrate prescription. To minimize the
ffect of selection bias on outcomes, the technique
f propensity score matching for clinical character-
stics was used and distortion of effective nitrate
reatment was excluded. The results of propen-
ity score matching showed that nitrate therapy
ad no impact on all-cause mortality (Fig. 8A)
nd cardiovascular events (cardiac death, non-fatal
einfarction, unstable angina, heart failure requir-
ng rehospitalization, and stroke) at 30-day, 60-day,
0-day, 6-month, 1-year, and 2-year follow-up peri-
ds (Fig. 8B). The study concluded that long-term
itrate therapy after AMI neither improves nor
ggravates prognosis. Prospective randomized clini-
al trials are warranted to determine the long-term
ffects of nitrate therapy on secondary prevention
f AMI.
onclusions
here are prospective and retrospective studies in a
ongitudinal method. The evidence level in prospec-
ive studies is higher than that in retrospective
tudies because prospective studies have less var-
ous biases. It takes much time to get the ﬁnal
esult in prospective studies while retrospective
[[
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[
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[
[
[8
studies are advantageous to form hasty conclu-
sions. Therefore, retrospective studies show their
ability to solve the urgent problems. The JACSS
database included more than 5000 consecutive AMI
patients and such a large database has not been
generally observed in Japanese retrospective stud-
ies regarding AMI. The results from JACSS data
vividly displayed the modern state of AMI in the
interventional era. They may be also helpful to
make plans for a novel prospective study. However,
there were several problems such as striking miss-
ing data in the JACSS database. Therefore, we are
now planning to perform a prospective study on AMI
(New JACSS) to solve these problems.
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